Erytech Pharma S.A. (ERYP)
Erytech Pharma S.A. (ERYP)
$6.82 USD
Updated Jul 16 6:55pm
Add ERYP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
ERYP News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Erytech Pharma S.A. (ERYP) Company Bio
ERYTECH Pharma Société Anonyme, a clinical-stage biopharmaceutical company, develops therapies for rare forms of cancer and orphan diseases in France and internationally. The company is developing a pipeline of product candidates targeting markets with unmet medical need using its proprietary ERYCAPS platform, a technology to encapsulate therapeutic drug substances inside red blood cells. It primarily focuses on the treatment of blood cancers, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), by depriving tumors of nutrients necessary for their survival. The company was founded in 2004 and is based in Lyon, France.
ERYP Stock Chart More Charts
ERYP Price/Volume Stats
| Current price | $6.82 |
| Prev. close | $6.67 |
| Day low | $6.65 |
| Day high | $7.03 |
| 50-day MA | $7.30 |
| 200-day MA | $8.37 |
| 52-week high | $11.89 |
| 52-week low | $5.45 |
| Volume | 5,400 |
| Avg. volume | 2,404 |
| Dividend yield | N/A |
| Market Cap | 122.35M |
ERYP Returns
| 1-mo | N/A |
| 3-mo | -10.14% |
| 6-mo | -14.75% |
| 1-year | -39.38% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 0.74% |
| 2018 | -69.26% |
| 2017 | N/A |
| 2016 | N/A |
| 2015 | N/A |
| 2014 | N/A |
Loading social stream, please wait...